<- Go Home
Paxman AB (publ)
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide.
Market Cap
SEK 1.4B
Volume
16.6K
Cash and Equivalents
SEK 36.3M
EBITDA
SEK 47.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
SEK 170.1M
Profit Margin
67.29%
52 Week High
SEK 73.60
52 Week Low
SEK 28.60
Dividend
N/A
Price / Book Value
9.11
Price / Earnings
52.24
Price / Tangible Book Value
12.17
Enterprise Value
SEK 1.4B
Enterprise Value / EBITDA
28.35
Operating Income
SEK 31.1M
Return on Equity
19.11%
Return on Assets
9.97
Cash and Short Term Investments
SEK 36.3M
Debt
SEK 17.7M
Equity
SEK 150.8M
Revenue
SEK 252.7M
Unlevered FCF
SEK 1.9M
Sector
Health Care Equipment and Supplies
Category
N/A